SEATTLE, May 6, 2015 /PRNewswire/ — LumiThera Inc., a medical device company focused on the development of non-invasive photobiomodulation (PBM) treatment for ocular disorders and disease, today announced Retired Congressman Norman Dicks has agreed to join LumiThera’s Advisory Board to assist in the company’s mission to treat vision impairment. Norman DeValois “Norm” Dicks was the… Continue reading
Passarella S, Karu T. Institute of Laser and Information Technologies of the Russian Academy of Sciences, 142190 Troitsk, Moscow Region, Russian Federation. Abstract In addition to the major functions performed by in the cell, mitochondria play a major role in cell-light interaction. Accordingly it is generally accepted that mitochondria are crucial in cell photobiomodulation; however… Continue reading
SEATTLE, June 9, 2014 /PRNewswire/ – LumiThera Inc., a medical device company focused on the development of non-invasive light emitting diode (LED) treatments for ocular disorders and disease, today announced Ret. Major General Gale Pollock has joined their Scientific Advisory Board. The first woman to serve as Acting Surgeon General of the United States Army… Continue reading
United Nations Headquarters (New York) presentation to the Global Health Impact Forum, 6th May 2014 by co founder James Carroll This 15 minute video starts with an overview of Photobiomodulation and low level light therapy as it relates to his company THOR Photomedicine. Later in the presentation James introduces Lumithera and our treatment for Age related… Continue reading
Begum R, Powner MB, Hudson N, Hogg C, Jeffery G Institute of Ophthalmology, University College London, London, United Kingdom. Abstract Inflammation is an umbrella feature of ageing. It is present in the aged retina and many retinal diseases including age-related macular degeneration (AMD). In ageing and in AMD mitochondrial function declines. In normal ageing this… Continue reading
Gkotsi D, Begum R, Salt T, Lascaratos G, Hogg C, Chau KY, Schapira AH, Jeffery G. Institute of Ophthalmology, University College London, 11-43 Bath Street, London EC1V 9EL, UK. Moorfields Eye Hospital, UK. Institute of Neurology, University College London, UK. Institute of Ophthalmology, University College London, 11-43 Bath Street, London EC1V 9EL, UK. Abstract Progressive… Continue reading
Ivandic BT, Ivandic T. University of Heidelberg , Otto Meyerhof Centre, Heidelberg, Germany OBJECTIVE: This case report describes the effects of low-level laser therapy (LLLT) in a single patient with retinitis pigmentosa (RP). Background data: RP is a heritable disorder of the retina, which eventually leads to blindness. No therapy is currently available. METHODS: LLLT… Continue reading
Tang J, Herda AA, Kern TS. Department of Ophthalmology, University of Kansas Medical Center, Prairie Village, Kansas, USA PURPOSE: Far-red/near-infrared phototherapy or photobiomodulation (PBM) has recently been reported to be an effective and non-invasive treatment method to inhibit lesions of diabetic retinopathy (DR) in animals. This study investigated the safety and efficacy of PBM in… Continue reading
Natoli R, Valter K, Barbosa M, Dahlstrom J, Rutar M, Kent A, Provis J The John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia ; ARC Centre of Excellence in Vision Science, Australian National University, Canberra, Australian Capital Territory, Australia ; ANU Medical School, Australian National University, Canberra, Australian Capital… Continue reading
Mii S, Kim C, Matsui H, Oharazawa H, Shi wa T, Takahashi H, Sakamoto A. Department of Anesthesiology, Nippon Medical School. Japan Abstract The authors applied near-infrared low-level laser irradiation (LLLI) directed to the stellate ganglion (SG) and to the common carotid artery (CCA), and compared the effects on central retinal artery blood flow using… Continue reading
